CASI Pharmaceuticals, Inc (DE) Quarterly Operating Lease, Liability in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Operating Lease, Liability for the quarter ending December 31, 2022 was $1.34M, a 38% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $1.34M -$822K -38% Dec 31, 2022 20-F 2023-04-26
Q3 2022 $1.56M -$1.09M -41.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.9M -$997K -34.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.88M +$300K +19% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.17M +$262K +13.8% Dec 31, 2021 20-F 2023-04-26
Q3 2021 $2.65M +$284K +12% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.89M +$1.29M +80.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.58M -$301K -16% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.9M -$297K -13.5% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $2.36M -$65K -2.68% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.6M -$1.18M -42.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.88M -$1.07M -36.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.2M Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.43M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.78M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $2.96M Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.